Lunai Bioworks Inc. SEC filings LNAI
Lunai Bioworks Inc. has 599 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (listing notice, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 25 | Form 25 | Nov 2, 2026 | — |
| EFFECT | Filing | Oct 26, 2026 | — |
| NT 10-K | Form nt 10-k | Sep 29, 2026 | Jun 30, 2026 |
| DEFR14A | Form defr14a | May 1, 2026 | — |
| DEFR14A | Form defr14a | Apr 15, 2026 | — |
| 425 | Form 425 | Mar 6, 2025 | — |
| NT 10-Q | Form nt 10-q | Feb 18, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Nov 6, 2024 | — |
| CORRESP | Letter to the SEC | Nov 4, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| NT 10-K | Form nt 10-k | Oct 1, 2024 | Jun 30, 2024 |
| CORRESP | Letter to the SEC | Oct 1, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2024 | — |
| CORRESP | Letter to the SEC | Aug 16, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2024 | — |
| CORRESP | Letter to the SEC | May 31, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Mar 11, 2024 | — |
| D | Filing | Feb 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| 425 | Form 425 | Oct 2, 2023 | — |
| 425 | Form 425 | Sep 29, 2023 | — |
| NT 10-K | Filing | Sep 29, 2023 | Jun 30, 2023 |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| NT 10-Q | Form nt 10-q | Nov 15, 2022 | Sep 30, 2022 |
| NT 10-K | Form nt 10-k | Sep 29, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Mar 8, 2022 | — |
| CORRESP | Letter to the SEC | Mar 4, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2022 | — |
| DEFR14A | Form defr14a | Feb 11, 2021 | — |
| EFFECT | Filing | Jul 20, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2020 | — |
| NT 10-Q | Filing | May 16, 2019 | Mar 31, 2019 |
| CERT | Filing | Dec 7, 2018 | — |
| 8-A12B | Filing | Dec 6, 2018 | — |
| NT 10-K | Filing | Oct 1, 2018 | Jun 30, 2018 |
| NT 10-Q | Notification of late filing | Nov 15, 2017 | Sep 30, 2017 |
| NT 10-K | Notification of late filing | Sep 29, 2017 | Jun 30, 2017 |
| UPLOAD | Letter from the SEC | Nov 18, 2016 | — |
| PRER14A | Amendment no. 1 to preliminary proxy statement | Nov 10, 2016 | — |
| CORRESP | Letter to the SEC | Nov 10, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2016 | — |
| D | Filing | Sep 15, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2014 | — |
| EFFECT | Filing | Aug 12, 2014 | — |
| CORRESP | Letter to the SEC | Aug 8, 2014 | — |
| CORRESP | Letter to the SEC | Aug 8, 2014 | — |
| CORRESP | Letter to the SEC | Aug 8, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2014 | — |
| CORRESP | Letter to the SEC | Jul 25, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2014 | — |
| CORRESP | Letter to the SEC | Jul 3, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2014 | — |
| CORRESP | Letter to the SEC | Jun 23, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2014 | — |
| CORRESP | Letter to the SEC | May 16, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2014 | — |
| SC 14F1 | Information statement | Jan 10, 2014 | — |
| NT 10-Q | Notification of late filing | Nov 15, 2013 | Sep 30, 2013 |
| NT 10-K | Notification of late filing | Jul 2, 2013 | Mar 31, 2013 |
| NT 10-Q | Quarterly extension for the period ending 06/12 | Aug 14, 2012 | Jun 30, 2012 |
| NT 10-K | Notification of late filing | Jul 2, 2012 | Mar 31, 2012 |
| NT 10-Q | Filing | Feb 15, 2012 | Dec 31, 2011 |
| 10-12G/A | Filing | Jan 31, 2012 | — |
| 10-12G/A | Form 10-12g/a | Nov 7, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2011 | — |
| 10-12G | Filing | Aug 12, 2011 | — |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LNAI (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Suite 906 Los Angeles, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527728
- Former names
- RENOVARO INC. (until Aug 26, 2025); RENOVARO BIOSCIENCES INC. (until Feb 7, 2024); Enochian Biosciences Inc (until Aug 1, 2023); DanDrit Biotech USA, Inc. (until Feb 23, 2018); Putnam Hills Corp. (until Feb 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.